Teclistamab versus lenalidomide-dexamethasone in high-risk smoldering multiple myeloma: a randomized phase 2 trial. (nature.com)

Authors: Nadeem O … Ghobrial IM Journal: Nature Medicine Published: 2026-09-11 DOI: https://doi.org/10.1038/s41591-026-04642-w